Why the study?
Data on outcomes of severe mitral regurgitation caused by mitral annular calcification, and the prognostic role of frailty and comorbidities in guiding management, are limited.
Does mitral valve intervention reduce all-cause mortality compared to conservative management in patients with severe mitral regurgitation due to severe mitral annular calcification?
Does mitral valve intervention reduce all-cause mortality compared to conservative management in patients with severe mitral regurgitation due to severe mitral annular calcification?
Mitral valve intervention improves survival in patients with severe mitral regurgitation due to severe mitral annular calcification, regardless of baseline frailty.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for mitral valve intervention in severe MR with MAC; prospective randomized trials needed before clinical adoption.
BACKGROUND: Mitral annular calcification (MAC) can be complicated by mitral regurgitation (MR). However, data on outcomes of severe MR caused by MAC are limited. This study evaluated outcomes of severe MR due to MAC and the prognostic significance of frailty and comorbidities in guiding management. METHODS: In this single-center, retrospective cohort study, we reviewed our echocardiographic database to identify patients with isolated severe MR due to severe MAC. The primary endpoint was all-cause mortality. The Society of Thoracic Surgeons (STS) risk score, Charlson Comorbidity Index (CCI), and a 3-point frailty index (hemoglobin, albumin, inactivity) were calculated. Echocardiographic parameters were recorded. RESULTS: Between January 2010 and August 2023, out of 10,061 patients with severe MAC on echocardiography, 128 patients with severe MR due to severe MAC were identified, and followed for a median of 134 days (IQR: 33-1812). Median age was 81 years; 72.7% were female. Forty-five patients (35.2%) underwent mitral valve (MV) intervention, and 83 (64.8%) received conservative management. During follow-up, 63 patients (49.2%) died. MV intervention improved survival, even after propensity score matching (p < 0.001). Higher frailty scores predicted poorer outcomes in the entire cohort (p = 0.004) and the conservative subgroup (p = 0.014) but not the surgical group (p = 0.406). CCI did not influence mortality when stratified by treatment. CONCLUSION: Patients with severe MR due to MAC were frail with multiple comorbidities and often managed conservatively. Frailty is associated with all-cause mortality, and MV intervention improves survival regardless of frailty status.
No takes yet. Share an insight, caveat, or question.
Zein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: